Uptake and availability of new outpatient cancer medicines in 2010-2021 in Nordic countries - survey of competent authorities.

ABSTRACT:

Background

Nordic countries excel in cancer care, but studies on uptake, costs, or managed entry agreements of cancer medicines have not been conducted recently. The aim of this study was to examine the uptake and availability of orally administered new cancer medicines in Nordic countries. Orally administered cancer medicines enable and are used in the community as part of outpatient care. Firstly, we studied the distribution, costs and adoption of managed entry agreements of these medicines, and secondly, uptake of and managed entry agreements for cancer medicines used in outpatient care that were granted marketing authorization in Europe in 2010-2021.

Methods

An E-mail survey of competent authorities, meaning pharmaceutical service organizers, payers or other government o

SUBMITTER: Sarnola K 

PROVIDER: S-EPMC10729379 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature